Prestige Consumer Healthcare (PBH) Short term Debt (2013 - 2021)
Prestige Consumer Healthcare (PBH) posted quarterly Short term Debt of $6.0 million for Q3 2021, down 29.62% quarter-over-quarter from $8.5 million in Q2 2015.
Prestige Consumer Healthcare (PBH) Short term Debt (2013 - 2021) Analysis & Trends
Prestige Consumer Healthcare's Short term Debt history runs 4 years deep, the most recent figure standing at $6.0 million for Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.37 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 6.00 Mn |
| Jun 30, 2015 | 8.53 Mn |
| Sep 30, 2014 | 7.20 Mn |
| Dec 31, 2013 | 48.29 Mn |